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LETTERS TO THE EDITOR
Electrocardiogram in Myocardial
Infarction: What Is Most Relevant?
Phibbs et al. (1) have recently published an interesting review
article on studies comparing Q wave with non–Q wave myocardial
infarction (MI). This classification of Q wave/non–Q wave gained
widespread use in the prereperfusion era because the rather passive
role of clinicians during the acute phase of infarction entailed
awaiting Q wave development (or lack thereof) for outcome
prediction in survivors. As Phibbs et al. indicated, the dichotomy
of Q wave/non–Q wave is inaccurate. The “non Q” category has
encompassed infarctions that have produced R-wave changes (i.e.,
posterior MI, decrease in R-wave amplitude) and are indeed Q
wave equivalents. In addition, I believe that the main limitation of
the Q/non Q dichotomy is that it erroneously polarized prognostic
groups. Several authors have alerted that within the non–Q wave
classification there were lumped together infarctions of the T type
(which manifest in the electrocardiogram [ECG] only with T wave
inversion) and of the ST type (which mainly manifest as ST
segment depression) (2,3). The latter type often included patients
with a previous infarction, and the underlying anatomy was usually
left main occlusion or extensive coronary disease with patchy
necrosis. A review of prethrombolytic studies would indicate that,
from a prognostic viewpoint, most Q wave infarctions were
between the T and the ST types of non–Q wave MI (4). Thus,
comparisons of Q versus non–Q wave outcomes have been fraught
with the problem that patients and control subjects were often
included in the same study arm.
The value of the “T versus ST” classification deserves further
evaluation in patients undergoing reperfusion. In a recent study we
analyzed over 1,500 patients admitted to the hospital with ST
segment elevation. Patients with a history of MI and Q wave
equivalences were also included. In this “retrolective” analysis, the
favorable prognostic significance of T wave inversion after throm-
bolysis was confirmed (5). When negative T waves were tested
separately from non–Q waves, both variables were associated with
similar 30-day survival rates. In a combined four-category plot,
patients with negative T waves, but absence of Q waves (i.e., T
type of non–Q wave MIs), were the most likely to survive at 30
days; patients in the opposite extreme (i.e., those without negative
T waves and with Q wave MIs) were the least likely to survive.
Other investigators have suggested that one possible reason for this
outcome is a high prevalence of patent culprit coronary arteries (6).
We also found that negative T waves were independent, powerful
predictors of a nearly four times higher survival rate after adjusting
for clinical variables and for new Q waves.
ST segment depression, by contrast, is known to predict cardiac
events and death (7), and no benefit from thrombolysis has been
shown in this group (8).
Whether or not the categorization “T type/ST type” is prospec-
tively confirmed, the terms “Q wave” and “non–Q wave” should be
redimensioned and used as one more ECG element to assist in
prognostic stratification, rather than as polar categories.
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REPLY
We appreciate Dr. Sgarbossa’s kind comments about our review
entitled “Q wave vs. non–Q wave myocardial infarction: a mean-
ingless distinction.” She points out, appropriately, the need to
include “Q wave equivalent” deflections in any comparative study,
but we would also like to reemphasize the overriding importance of
comparing first myocardial infarctions (MIs) only in this type of
study, because subsequent MIs have a much higher morbidity and
mortality and usually do not generate Q waves. The main thrust of
our review was that there is no basis for the notion that the non–Q
wave MI is somehow “unstable,” with an increased risk of post-MI
acute events, and with this we are sure Dr. Sgarbossa agrees. In
fact, we quoted a study from Sgarbossa’s group (1) supporting this
point of view in our review.
She quotes her own study of T wave polarity after MI, in
combination with the presence or absence of Q waves, as a
prognostic index in both the Q wave and non–Q wave categories.
Because this report has appeared only in abstract so far, it is
impossible to comment on the details of the protocol.
Were only first MIs included in the study? An outcome study
based on two variables can be very tricky, as any statistician will
attest, but the results may well be significant.
Dr. Sgarbossa comments on several other studies addressing the
value of ST segment depression and T wave inversion as prognos-
tic indexes. This element was not included in our review, because
we were concerned only with the presence or absence of depolar-
ization abnormality as a clinical marker. The studies cited by
Sgarbossa, suggesting that the type of S-T-T deformity may
contribute important prognostic information, are all based on
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assessment of only non–Q-wave MIs, which dates from a period
when the non–Q wave MI was assumed to be a valid subset with
unique characteristics. It is to be hoped that this misconception has
been permanently put to rest and, further, that investigations of
outcome after MI will avoid the egregious error of combining
random mixtures of first and subsequent infarcts.
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Does Flow Reserve Match Contractility?
I have read with great interest the report by Barilla` et al. (1). The
data reported are intriguing because, to the best of my knowledge,
this is the first report indicating that the restoration of regional
contractility during low dose dobutamine administration may
occur despite different perfusion patterns, depending on the
presence or absence of collateral filling.
Let me raise an issue not addressed in the Discussion of Barilla`’s
article. I definitely agree with Bonow (2) that the increase in flow
in patients with collateral filling is expected, because the drop of
pressure beyond the fixed obstruction can increase the flow, despite
the coronary driving pressure’s being unchanged. The no-
measurable-flow response in patients without collateral channels
can also be expected. In fact, why should the flow increase through
a stenosis or an occlusion? Irrespective of flow regimen, the authors
(1) noted an amelioration in contractility of dysfunctional myocar-
dium—one that was still present at 2-methoxy-isobutyl-isonitrile
(MIBI) administration and during the time allowed for it to
distribute to the myocardium (i.e., up to 8 min), I presume,
because no mention was ever made to subsequent deterioration of
wall motion. This is an astonishingly long time, which would more
appropriately define the response to low dose dobutamine of
stunned myocardium (but this was not the case, as indicated by the
low sestamibi uptake). It seems inconceivable that such a pro-
longed increase in contractility may occur in the absence of an
adequate increase in blood flow, the situation being absolutely
different from the postextrasystolic potentiation of contractility,
when myocytes burn their energy stores all in one go. By contrast,
the increase in contractility of ischemic but viable myocardium at
low dose dobutamine is a short-lived phenomenon: it may begin at
very low dosage (as low as 2.5 mg/kg body weight per min, in our
experience) and usually fades away at 10 mg/kg per min, seldom at
20 mg/kg per min. In patients with very severe coronary stenosis or
coronary occlusion without collateral blood filling, a biphasic
response to dobutamine should be expected at a dosage even lower
than that at which the authors injected technetium-99m sestamibi.
Given this, as well as the notion of the ischemic cascade (3,4), I
make the point that Barilla` et al. (1) described an intermediate
phase of the biphasic response phenomenon—that is, the time
when the flow reserve is exhausted, but wall contractility has not
yet deteriorated in response to forthcoming or ongoing ischemia,
or both. I suggest that this possibility is whispered to the reader.
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We are grateful to Dr. Barletta for his comments. Obviously, the
findings we have reported constitute an intermediate step of a
biphasic response phenomenon, as stated by Dr. Barletta. How-
ever, a 5-min step protocol for low dose dobutamine echocardi-
ography is common (1,2), and a biphasic response (i.e., wall
motion improvement followed by worsening) is rarely observed at
low doses of 5 to 10 mg/kg body weight per min (3). Nevertheless,
no change in wall motion and thickening occurred during the
3 min after tracer injection, even when we used 10 mg/kg per min
of dobutamine.
We also wish to emphasize that our study was not intended to
describe the behavior of inotropic contractile reserve during low
dose dobutamine infusion, but it was aimed at investigating the
pathophysiologic and clinical implications of the presumed mis-
match between perfusion and contractility in areas with severely
hypoperfused viable myocardium.
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